Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M, Forte N, Sabatino L, Tomaselli E, Parente D, Febbraro A, Colantuoni V. Pancione M, et al. Among authors: febbraro a. Hum Pathol. 2009 May;40(5):714-25. doi: 10.1016/j.humpath.2008.08.019. Epub 2009 Jan 3. Hum Pathol. 2009. PMID: 19121846
A novel germline mutation in peroxisome proliferator-activated receptor gamma gene associated with large intestine polyp formation and dyslipidemia.
Capaccio D, Ciccodicola A, Sabatino L, Casamassimi A, Pancione M, Fucci A, Febbraro A, Merlino A, Graziano G, Colantuoni V. Capaccio D, et al. Among authors: febbraro a. Biochim Biophys Acta. 2010 Jun;1802(6):572-81. doi: 10.1016/j.bbadis.2010.01.012. Epub 2010 Feb 1. Biochim Biophys Acta. 2010. PMID: 20123124 Free article.
Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.
Pancione M, Sabatino L, Fucci A, Carafa V, Nebbioso A, Forte N, Febbraro A, Parente D, Ambrosino C, Normanno N, Altucci L, Colantuoni V. Pancione M, et al. Among authors: febbraro a. PLoS One. 2010 Dec 3;5(12):e14229. doi: 10.1371/journal.pone.0014229. PLoS One. 2010. Retraction in: PLoS One. 2019 Dec 27;14(12):e0227376. doi: 10.1371/journal.pone.0227376. PMID: 21151932 Free PMC article. Retracted.
Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.
Giordano G, Febbraro A, Tomaselli E, Sarnicola ML, Parcesepe P, Parente D, Forte N, Fabozzi A, Remo A, Bonetti A, Manfrin E, Ghasemi S, Ceccarelli M, Cerulo L, Bazzoni F, Pancione M. Giordano G, et al. Among authors: febbraro a. J Exp Clin Cancer Res. 2015 Oct 1;34:108. doi: 10.1186/s13046-015-0225-7. J Exp Clin Cancer Res. 2015. PMID: 26427914 Free PMC article.
Cancer drug related cardiotoxicity during breast cancer treatment.
Giordano G, Spagnuolo A, Olivieri N, Corbo C, Campagna A, Spagnoletti I, Pennacchio RM, Campidoglio S, Pancione M, Palladino L, Villari B, Febbraro A. Giordano G, et al. Among authors: febbraro a. Expert Opin Drug Saf. 2016 Aug;15(8):1063-74. doi: 10.1080/14740338.2016.1182493. Epub 2016 Jul 6. Expert Opin Drug Saf. 2016. PMID: 27120499 Review.
71 results